Intrinsic value of Aceto - ACET

Previous Close

$7.21

  Intrinsic Value

$31.12

stock screener

  Rating & Target

str. buy

+332%

Previous close

$7.21

 
Intrinsic value

$31.12

 
Up/down potential

+332%

 
Rating

str. buy

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of ACET stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

Please visit our new site that uses elements of artificial intelligence for stock valuation: artificial intelligence value of Aceto (ACET) stock.

STOCK VALUATION INPUT DATA

Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Shares outstanding, mln

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2017(a)
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  14.13
  44.50
  40.55
  37.00
  33.80
  30.92
  28.32
  25.99
  23.89
  22.00
  20.30
  18.77
  17.40
  16.16
  15.04
  14.04
  13.13
  12.32
  11.59
  10.93
  10.34
  9.80
  9.32
  8.89
  8.50
  8.15
  7.84
  7.55
  7.30
  7.07
  6.86
Revenue, $m
  638
  922
  1,296
  1,775
  2,375
  3,109
  3,990
  5,027
  6,228
  7,599
  9,141
  10,857
  12,746
  14,805
  17,032
  19,423
  21,973
  24,680
  27,540
  30,550
  33,708
  37,012
  40,462
  44,059
  47,804
  51,701
  55,752
  59,962
  64,338
  68,885
  73,610
Variable operating expenses, $m
 
  816
  1,138
  1,550
  2,066
  2,697
  3,454
  4,346
  5,379
  6,557
  7,884
  9,336
  10,960
  12,730
  14,645
  16,701
  18,894
  21,221
  23,680
  26,268
  28,984
  31,825
  34,791
  37,884
  41,105
  44,455
  47,938
  51,559
  55,321
  59,231
  63,294
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  608
  816
  1,138
  1,550
  2,066
  2,697
  3,454
  4,346
  5,379
  6,557
  7,884
  9,336
  10,960
  12,730
  14,645
  16,701
  18,894
  21,221
  23,680
  26,268
  28,984
  31,825
  34,791
  37,884
  41,105
  44,455
  47,938
  51,559
  55,321
  59,231
  63,294
Operating income, $m
  31
  106
  158
  225
  309
  412
  535
  681
  849
  1,041
  1,257
  1,522
  1,786
  2,075
  2,387
  2,722
  3,080
  3,459
  3,860
  4,281
  4,724
  5,187
  5,671
  6,175
  6,700
  7,246
  7,813
  8,404
  9,017
  9,654
  10,316
EBITDA, $m
  55
  148
  209
  286
  382
  500
  642
  809
  1,002
  1,223
  1,471
  1,747
  2,051
  2,383
  2,741
  3,126
  3,536
  3,972
  4,432
  4,916
  5,424
  5,956
  6,511
  7,090
  7,693
  8,320
  8,972
  9,650
  10,354
  11,085
  11,846
Interest expense (income), $m
  8
  12
  22
  34
  51
  71
  96
  126
  161
  202
  248
  301
  359
  423
  493
  569
  650
  737
  829
  926
  1,028
  1,136
  1,248
  1,365
  1,487
  1,615
  1,747
  1,885
  2,028
  2,176
  2,331
Earnings before tax, $m
  17
  94
  136
  191
  259
  341
  440
  555
  688
  839
  1,009
  1,221
  1,427
  1,652
  1,894
  2,153
  2,429
  2,722
  3,031
  3,355
  3,696
  4,052
  4,423
  4,810
  5,212
  5,631
  6,067
  6,519
  6,989
  7,478
  7,985
Tax expense, $m
  6
  25
  37
  52
  70
  92
  119
  150
  186
  227
  272
  330
  385
  446
  511
  581
  656
  735
  818
  906
  998
  1,094
  1,194
  1,299
  1,407
  1,520
  1,638
  1,760
  1,887
  2,019
  2,156
Net income, $m
  11
  68
  100
  139
  189
  249
  321
  405
  502
  613
  737
  891
  1,042
  1,206
  1,382
  1,572
  1,773
  1,987
  2,213
  2,450
  2,698
  2,958
  3,229
  3,511
  3,805
  4,111
  4,429
  4,759
  5,102
  5,459
  5,829

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  58
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  1,038
  1,416
  1,990
  2,727
  3,648
  4,776
  6,129
  7,722
  9,567
  11,672
  14,042
  16,678
  19,579
  22,742
  26,163
  29,835
  33,753
  37,911
  42,304
  46,928
  51,778
  56,854
  62,154
  67,679
  73,432
  79,417
  85,640
  92,108
  98,829
  105,814
  113,073
Adjusted assets (=assets-cash), $m
  980
  1,416
  1,990
  2,727
  3,648
  4,776
  6,129
  7,722
  9,567
  11,672
  14,042
  16,678
  19,579
  22,742
  26,163
  29,835
  33,753
  37,911
  42,304
  46,928
  51,778
  56,854
  62,154
  67,679
  73,432
  79,417
  85,640
  92,108
  98,829
  105,814
  113,073
Revenue / Adjusted assets
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
Average production assets, $m
  187
  270
  380
  520
  696
  911
  1,169
  1,473
  1,825
  2,226
  2,678
  3,181
  3,735
  4,338
  4,990
  5,691
  6,438
  7,231
  8,069
  8,951
  9,876
  10,844
  11,855
  12,909
  14,007
  15,148
  16,335
  17,569
  18,851
  20,183
  21,568
Working capital, $m
  249
  296
  416
  570
  762
  998
  1,281
  1,614
  1,999
  2,439
  2,934
  3,485
  4,091
  4,752
  5,467
  6,235
  7,053
  7,922
  8,840
  9,807
  10,820
  11,881
  12,988
  14,143
  15,345
  16,596
  17,896
  19,248
  20,652
  22,112
  23,629
Total debt, $m
  354
  616
  979
  1,444
  2,027
  2,740
  3,594
  4,601
  5,767
  7,098
  8,595
  10,261
  12,095
  14,094
  16,256
  18,577
  21,053
  23,681
  26,457
  29,379
  32,445
  35,652
  39,002
  42,494
  46,130
  49,913
  53,846
  57,933
  62,181
  66,595
  71,183
Total liabilities, $m
  633
  895
  1,258
  1,723
  2,306
  3,019
  3,873
  4,880
  6,046
  7,377
  8,874
  10,540
  12,374
  14,373
  16,535
  18,856
  21,332
  23,960
  26,736
  29,658
  32,724
  35,931
  39,281
  42,773
  46,409
  50,192
  54,125
  58,212
  62,460
  66,874
  71,462
Total equity, $m
  405
  521
  732
  1,003
  1,343
  1,758
  2,255
  2,842
  3,521
  4,295
  5,167
  6,137
  7,205
  8,369
  9,628
  10,979
  12,421
  13,951
  15,568
  17,269
  19,054
  20,922
  22,872
  24,906
  27,023
  29,226
  31,516
  33,896
  36,369
  38,939
  41,611
Total liabilities and equity, $m
  1,038
  1,416
  1,990
  2,726
  3,649
  4,777
  6,128
  7,722
  9,567
  11,672
  14,041
  16,677
  19,579
  22,742
  26,163
  29,835
  33,753
  37,911
  42,304
  46,927
  51,778
  56,853
  62,153
  67,679
  73,432
  79,418
  85,641
  92,108
  98,829
  105,813
  113,073
Debt-to-equity ratio
  0.874
  1.180
  1.340
  1.440
  1.510
  1.560
  1.590
  1.620
  1.640
  1.650
  1.660
  1.670
  1.680
  1.680
  1.690
  1.690
  1.690
  1.700
  1.700
  1.700
  1.700
  1.700
  1.710
  1.710
  1.710
  1.710
  1.710
  1.710
  1.710
  1.710
  1.710
Adjusted equity ratio
  0.354
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368
  0.368

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  11
  68
  100
  139
  189
  249
  321
  405
  502
  613
  737
  891
  1,042
  1,206
  1,382
  1,572
  1,773
  1,987
  2,213
  2,450
  2,698
  2,958
  3,229
  3,511
  3,805
  4,111
  4,429
  4,759
  5,102
  5,459
  5,829
Depreciation, amort., depletion, $m
  24
  43
  51
  61
  73
  88
  107
  128
  153
  182
  214
  226
  265
  308
  354
  404
  457
  513
  572
  635
  700
  769
  841
  916
  993
  1,074
  1,159
  1,246
  1,337
  1,431
  1,530
Funds from operations, $m
  38
  111
  150
  200
  262
  337
  428
  533
  655
  794
  950
  1,117
  1,307
  1,513
  1,736
  1,975
  2,230
  2,500
  2,785
  3,084
  3,398
  3,727
  4,069
  4,427
  4,798
  5,185
  5,587
  6,005
  6,439
  6,890
  7,359
Change in working capital, $m
  -7
  91
  120
  154
  193
  236
  283
  333
  386
  440
  495
  551
  606
  661
  715
  767
  819
  869
  918
  966
  1,014
  1,061
  1,108
  1,155
  1,202
  1,251
  1,300
  1,352
  1,405
  1,460
  1,517
Cash from operations, $m
  45
  20
  30
  46
  69
  102
  145
  200
  270
  354
  455
  566
  700
  852
  1,022
  1,208
  1,411
  1,631
  1,867
  2,118
  2,385
  2,666
  2,962
  3,272
  3,596
  3,934
  4,287
  4,653
  5,034
  5,431
  5,842
Maintenance CAPEX, $m
  0
  -13
  -19
  -27
  -37
  -49
  -65
  -83
  -104
  -129
  -158
  -190
  -226
  -265
  -308
  -354
  -404
  -457
  -513
  -572
  -635
  -700
  -769
  -841
  -916
  -993
  -1,074
  -1,159
  -1,246
  -1,337
  -1,431
New CAPEX, $m
  -5
  -83
  -110
  -140
  -176
  -215
  -258
  -304
  -352
  -402
  -452
  -503
  -553
  -603
  -652
  -700
  -747
  -793
  -838
  -882
  -925
  -968
  -1,011
  -1,054
  -1,097
  -1,142
  -1,187
  -1,234
  -1,282
  -1,332
  -1,385
Cash from investing activities, $m
  -276
  -96
  -129
  -167
  -213
  -264
  -323
  -387
  -456
  -531
  -610
  -693
  -779
  -868
  -960
  -1,054
  -1,151
  -1,250
  -1,351
  -1,454
  -1,560
  -1,668
  -1,780
  -1,895
  -2,013
  -2,135
  -2,261
  -2,393
  -2,528
  -2,669
  -2,816
Free cash flow, $m
  -231
  -76
  -99
  -121
  -143
  -163
  -178
  -186
  -186
  -177
  -155
  -127
  -79
  -16
  61
  154
  260
  381
  516
  664
  825
  998
  1,182
  1,377
  1,583
  1,799
  2,025
  2,261
  2,506
  2,761
  3,026
Issuance/(repayment) of debt, $m
  232
  276
  363
  465
  582
  713
  855
  1,007
  1,166
  1,330
  1,498
  1,666
  1,834
  1,999
  2,162
  2,321
  2,476
  2,628
  2,776
  2,922
  3,065
  3,208
  3,350
  3,492
  3,636
  3,783
  3,933
  4,088
  4,248
  4,414
  4,588
Issuance/(repurchase) of shares, $m
  1
  92
  112
  132
  150
  166
  177
  181
  177
  162
  136
  79
  26
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  228
  368
  475
  597
  732
  879
  1,032
  1,188
  1,343
  1,492
  1,634
  1,745
  1,860
  1,999
  2,162
  2,321
  2,476
  2,628
  2,776
  2,922
  3,065
  3,208
  3,350
  3,492
  3,636
  3,783
  3,933
  4,088
  4,248
  4,414
  4,588
Total cash flow (excl. dividends), $m
  -3
  291
  376
  476
  589
  716
  854
  1,002
  1,156
  1,316
  1,478
  1,618
  1,781
  1,983
  2,223
  2,474
  2,737
  3,009
  3,292
  3,586
  3,890
  4,205
  4,531
  4,869
  5,219
  5,582
  5,958
  6,349
  6,754
  7,176
  7,614
Retained Cash Flow (-), $m
  -101
  -160
  -211
  -271
  -339
  -415
  -498
  -586
  -679
  -775
  -872
  -970
  -1,068
  -1,164
  -1,259
  -1,351
  -1,442
  -1,530
  -1,617
  -1,701
  -1,785
  -1,868
  -1,950
  -2,033
  -2,117
  -2,203
  -2,290
  -2,380
  -2,473
  -2,570
  -2,671
Prev. year cash balance distribution, $m
 
  44
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  175
  165
  205
  250
  301
  356
  415
  477
  541
  606
  648
  713
  819
  964
  1,123
  1,295
  1,479
  1,676
  1,885
  2,105
  2,337
  2,581
  2,836
  3,102
  3,379
  3,668
  3,969
  4,281
  4,605
  4,942
Discount rate, %
 
  7.30
  7.67
  8.05
  8.45
  8.87
  9.32
  9.78
  10.27
  10.79
  11.32
  11.89
  12.49
  13.11
  13.77
  14.45
  15.18
  15.93
  16.73
  17.57
  18.45
  19.37
  20.34
  21.35
  22.42
  23.54
  24.72
  25.96
  27.25
  28.62
  30.05
PV of cash for distribution, $m
 
  163
  142
  162
  181
  197
  209
  216
  218
  215
  207
  188
  174
  165
  159
  148
  135
  120
  103
  87
  71
  57
  44
  33
  24
  17
  12
  8
  5
  3
  2
Current shareholders' claim on cash, %
  100
  73.4
  56.1
  44.7
  36.8
  31.3
  27.3
  24.5
  22.5
  21.1
  20.2
  19.8
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7
  19.7

Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company's business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. As of June 30, 2016, the Pharmaceutical Ingredients segment had two product groups: Active Pharmaceutical Ingredients and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products.

FINANCIAL RATIOS  of  Aceto (ACET)

Valuation Ratios
P/E Ratio 19.7
Price to Sales 0.3
Price to Book 0.5
Price to Tangible Book
Price to Cash Flow 4.8
Price to Free Cash Flow 5.4
Growth Rates
Sales Growth Rate 14.1%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -58.3%
Cap. Spend. - 3 Yr. Gr. Rate 20.1%
Financial Strength
Quick Ratio 4
Current Ratio 0
LT Debt to Equity 84%
Total Debt to Equity 87.4%
Interest Coverage 3
Management Effectiveness
Return On Assets 2%
Ret/ On Assets - 3 Yr. Avg. 5.5%
Return On Total Capital 1.9%
Ret/ On T. Cap. - 3 Yr. Avg. 6.7%
Return On Equity 3.1%
Return On Equity - 3 Yr. Avg. 9.7%
Asset Turnover 0.8
Profitability Ratios
Gross Margin 22.1%
Gross Margin - 3 Yr. Avg. 24.1%
EBITDA Margin 7.7%
EBITDA Margin - 3 Yr. Avg. 11%
Operating Margin 4.7%
Oper. Margin - 3 Yr. Avg. 8.4%
Pre-Tax Margin 2.7%
Pre-Tax Margin - 3 Yr. Avg. 7.4%
Net Profit Margin 1.7%
Net Profit Margin - 3 Yr. Avg. 4.7%
Effective Tax Rate 35.3%
Eff/ Tax Rate - 3 Yr. Avg. 36.5%
Payout Ratio 72.7%

ACET stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the ACET stock intrinsic value calculation we used $638 million for the last fiscal year's total revenue generated by Aceto. The default revenue input number comes from 2017 income statement of Aceto. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our ACET stock valuation model: a) initial revenue growth rate of 44.5% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 7.3%, whose default value for ACET is calculated based on our internal credit rating of Aceto, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Aceto.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of ACET stock the variable cost ratio is equal to 89.7%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for ACET stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for Aceto.

Corporate tax rate of 27% is the nominal tax rate for Aceto. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the ACET stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for ACET are equal to 29.3%.

Life of production assets of 14.1 years is the average useful life of capital assets used in Aceto operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for ACET is equal to 32.1%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $405 million for Aceto - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 30.641 million for Aceto is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Aceto at the current share price and the inputted number of shares is $0.2 billion.

RELATED COMPANIES Price Int.Val. Rating
PFE Pfizer 35.74 28.29  sell
NVS Novartis ADR 85.20 39.03  str.sell
KWR Quaker Chemica 148.41 63.81  str.sell
MRK Merck&Co 54.57 30.23  sell
PBH Prestige Brand 35.00 32.10  sell
VRX Valeant Pharma 18.27 18.36  hold
GSK GlaxoSmithKlin 36.57 42.07  hold
CBM Cambrex 52.25 110.74  str.buy

COMPANY NEWS

▶ ACETO Appoints Edward J. Borkowski Chief Financial Officer   [Feb-16-18 08:00AM  GlobeNewswire]
▶ Why Aceto Corporation's Shares Plunged 17% Today   [Feb-02-18 12:17PM  Motley Fool]
▶ Aceto Corporation to Host Earnings Call   [07:00AM  ACCESSWIRE]
▶ Top Healthcare Dividend Picks For The Day   [05:02AM  Simply Wall St.]
▶ Aceto reports 2Q loss   [Feb-01-18 05:27PM  Associated Press]
▶ Why Aceto Corporation (NASDAQ:ACET) Could Be A Buy   [Jan-31-18 01:09PM  Simply Wall St.]
▶ Investors Favorite Healthcare Dividend Stocks   [Dec-29-17 05:02AM  Simply Wall St.]
▶ ACETO Board of Directors Declares Quarterly Cash Dividend   [Dec-07-17 03:32PM  GlobeNewswire]
▶ New Strong Sell Stocks for December 4th   [Dec-04-17 09:13AM  Zacks]
▶ November Healthcare Dividend Stocks To Look Out For   [Nov-24-17 05:02AM  Simply Wall St.]
▶ New Strong Sell Stocks for November 16th   [Nov-16-17 09:45AM  Zacks]
▶ ETFs with exposure to Aceto Corp. : November 7, 2017   [Nov-07-17 09:32AM  Capital Cube]
▶ Aceto Corporation to Host Earnings Call   [07:00AM  ACCESSWIRE]
▶ Aceto posts 1Q profit   [06:23AM  Associated Press]
▶ ACETO Reports Fiscal 2018 First Quarter Results   [Nov-02-17 05:00PM  GlobeNewswire]
▶ ETFs with exposure to Aceto Corp. : October 25, 2017   [Oct-25-17 09:45AM  Capital Cube]
▶ ETFs with exposure to Aceto Corp. : October 3, 2017   [Oct-03-17 10:48AM  Capital Cube]
▶ ACETO Appoints William C. Kennally, III President and CEO   [Sep-27-17 04:54PM  GlobeNewswire]
▶ ETFs with exposure to Aceto Corp. : September 1, 2017   [Sep-01-17 06:41PM  Capital Cube]
▶ Aceto posts 4Q profit   [Aug-24-17 10:22PM  Associated Press]
▶ 5 Stocks to Bet on New Analyst Coverage   [Aug-21-17 09:56AM  Zacks]
▶ ACETO to Present at the Singular Summer Solstice Conference   [Jul-07-17 09:00AM  GlobeNewswire]
▶ ETFs with exposure to Aceto Corp. : June 15, 2017   [Jun-15-17 12:53PM  Capital Cube]
▶ ETFs with exposure to Aceto Corp. : June 2, 2017   [Jun-02-17 01:48PM  Capital Cube]
▶ ETFs with exposure to Aceto Corp. : May 23, 2017   [May-23-17 12:23PM  Capital Cube]
▶ Aceto posts 3Q profit   [May-04-17 07:44PM  Associated Press]
▶ Aceto Corp. Value Analysis (NASDAQ:ACET) : April 24, 2017   [Apr-24-17 03:03PM  Capital Cube]
▶ Should You Get Rid of INC Research (INCR) Now?   [Mar-08-17 08:47AM  Zacks]
▶ Top Ranked Value Stocks to Buy for March 6th   [Mar-06-17 09:32AM  Zacks]
▶ Should You Get Rid of Ensign Group (ENSG) Now?   [Mar-03-17 08:42AM  Zacks]
Financial statements of ACET
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.